| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| LYEL LYELL IMMUNOPHARMA, INC. | SALEGRANT Stock grant | 44,000 | — | — | 2,774,980 | Jul 27, 2026 | Jul 27, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALEGRANT Stock grant | 38,500 | — | — | 2,818,980 | Jul 27, 2026 | Jul 27, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALE10b5-1 10b5-1 plan | 10 | $13.70 | $137 | 2,857,480 | Jul 17, 2026 | Jul 18, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALE10b5-1 10b5-1 plan | 10 | $13.73 | $137 | 2,857,490 | Jul 16, 2026 | Jul 17, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALEGRANT Stock grant | 76,000 | — | — | 2,857,500 | Jun 29, 2026 | Jul 1, 2026 ↗ | View → |
| LYEL LYELL IMMUNOPHARMA, INC. | SALEGRANT Stock grant | 66,500 | — | — | 2,933,500 | Jun 15, 2026 | Jun 18, 2026 ↗ | View → |